Gsk (GSK) Net Cash Flow (2009 - 2026)
Gsk (GSK) posted quarterly Net Cash Flow of $2.7 billion for Q2 2026, up 78.1% year-over-year from $1.5 billion in Q2 2025, and up 1172.04% quarter-over-quarter from $210.3 million in Q1 2026.
Gsk (GSK) Net Cash Flow (2009 - 2026) Analysis & Trends
Gsk's Net Cash Flow history runs 18 years deep, the most recent figure standing at $2.7 billion for Q2 2026.
- In Q2 2026, Net Cash Flow rose 78.1% year-over-year to $2.7 billion; the TTM figure through Jun 2026 stood at $5.2 billion (down 11.73% YoY), while the FY2025 annual figure was $1.4 billion, down 44.53% from the prior year.
- Net Cash Flow for Q2 2026 stood at $2.7 billion, up from $210.3 million in the prior quarter.
- The five-year high for Net Cash Flow was $6.2 billion in Q4 2023, with the low at -$7.4 billion in Q4 2022.
- The 5-year median for Net Cash Flow is $1.4 billion (2024), against an average of $891.3 million.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow slumped 2544.1% in 2022, then soared 1314.2% in 2025.
- Gsk's Net Cash Flow stood at -$7.4 billion in 2022, then surged by 184.03% to $6.2 billion in 2023, then tumbled by 78.29% to $1.4 billion in 2024, then tumbled by 55.74% to $599.9 million in 2025, then surged by 345.96% to $2.7 billion in 2026.
- Business Quant data shows GSK's Net Cash Flow at $2.7 billion in Q2 2026, $210.3 million in Q1 2026, and $599.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -6.80 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 2.68 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 27.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.68 Bn |
| Jun 30, 2026 | 2.68 Bn |
| Mar 31, 2026 | 210.32 Mn |
| Mar 31, 2026 | 210.32 Mn |
| Dec 31, 2025 | 599.90 Mn |
| Dec 31, 2025 | 599.90 Mn |
| Sep 30, 2025 | 1.68 Bn |
| Sep 30, 2025 | 1.68 Bn |
| Jun 30, 2025 | 1.50 Bn |
| Jun 30, 2025 | 1.50 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.72 Bn |
| Sep 30, 2024 | 1.72 Bn |
| Jun 30, 2024 | 414.01 Mn |
| Jun 30, 2024 | 414.01 Mn |
| Mar 31, 2024 | -105.29 Mn |
| Mar 31, 2024 | -105.29 Mn |